|
advertisement
|
|
|
| Journal Articles Details
|
|
More November, 2004 pharmacogenomics journal articles.- [Pharmacogenomics of the growth hormone : polymorphism of the receptor in the front line.]
by Bougnères P.
Journal: Med Sci (Paris). 20(11):964-965
- Pharmacogenomics in cancer therapy: is host genome variability important?
by Petros WP, Evans WE.
Journal: Trends Pharmacol Sci. 25(9):457-64
- Pharmacogenetics of nicotine metabolism in twins: methods and procedures.
by Swan GE, Benowitz NL, Jacob P, Lessov CN, Tyndale RF, Wilhelmsen K, Krasnow RE, McElroy MR, Moore SE, Wambach M.
Journal: Twin Res. 7(5):435-48
- Use of pharmacogenetics to guide warfarin therapy.
by Voora D, McLeod HL, Eby C, Gage BL.
Journal: Timely Top Med Cardiovasc Dis. 07 2004;8:E4
- Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
by Murphy GM, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF.
Journal: Arch Gen Psychiatry. 61(11):1163-9
- [P-glycoprotein--a pump of significance for drug response]
by Molden E.
Journal: Tidsskr Nor Laegeforen. 124(22):2921-3
- Identification of single-nucleotide polymorphisms of the human neurokinin 1 receptor gene and pharmacological characterization of a Y192H variant.
by Randolph GP, Simon JS, Arreaza MG, Qiu P, Lachowicz JE, Duffy RA.
Journal: Pharmacogenomics J. 4(6):394-402
- Pharmacogenetics and cardiovascular disease management.
by Weston CF.
Journal: Hosp Med. 65(10):594-8
- Pharmacogenetics-based new therapeutic concepts.
by Roots I, Gerloff T, Meisel C, Kirchheiner J, Goldammer M, Kaiser R, Laschinski G, Brockmöller J, Cascorbi I, Kleeberg U, Hildebrandt AG.
Journal: Drug Metab Rev. 36(3-4):617-38
- Internet based clinical trial protocols -- as applied to a study of warfarin pharmacogenetics.
by Lindh JD, Kublickas M, Westgren M, Rane A.
Journal: Br J Clin Pharmacol. 58(5):482-7
- Differential display polymerase chain reaction reveals increased expression of striatal rat glia-derived nexin following chronic clozapine treatment.
by Chong VZ, Costain W, Marriott J, Sindwani S, Knauer DJ, Wang JF, Young LT, Maccrimmon D, Mishra RK.
Journal: Pharmacogenomics J. 4(6):379-87
- Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors.
by García-Colunga J, Vázquez-Gómez E, Miledi R.
Journal: Pharmacogenomics J. 4(6):388-93
- In genetic control of disease, does 'race' matter?
by Goldstein DB, Hirschhorn JN.
Journal: Nat Genet. 36(12):1243-1244
- Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management.
by Kajinami K, Takekoshi N, Brousseau ME, Schaefer EJ.
Journal: Atherosclerosis. 177(2):219-34
- Attention-deficit hyperactivity disorder (ADHD).
by Voeller KK.
Journal: J Child Neurol. 19(10):798-814
- Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).
by Shah RR.
Journal: Br J Clin Pharmacol. 58(5):452-69
- Gene expression microarray technologies in the development of new therapeutic agents.
by Clarke PA, te Poele R, Workman P.
Journal: Eur J Cancer. 40(17):2560-91
- Medication errors in pediatrics-the octopus evading defeat.
by Sullivan JE, Buchino JJ.
Journal: J Surg Oncol. November 2004;88(3):182-188
- Interethnic variability of ERCC2 polymorphisms.
by King CR, Yu J, Freimuth RR, McLeod HL, Marsh S.
Journal: Pharmacogenomics J. 11 2004;:
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|